Indian Council of Medical Research Director General Balram Bhargava said the purpose of the COVID vaccine drive would be to break the chain of viral transmission.
FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte
If the government had paid enough to begin with, or if it had made serious advance purchase commitments that allowed the vaccine producers to mobilise necessary investment, then it is possible to imagine more free or subsidised vaccines such as are available in developed economies, asserts Mihir S Sharma.
Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation
'Vaccination is very important for an economy to start functioning properly.'
Investors cheered a sharp decline in the Current Account Deficit, which stands at a 4 year low as exports picked up and gold imports reduced.
'Your body will be able to deal with Omicron at any time, but it depends (on when) if you are vaccinated.'
COVID-19 has emerged as an important form of diplomatic currency around the world as nations try to showcase their soft power gains. In this race, India has an edge as India is already a pharmaceutical giant having produced some 60 per cent of global vaccines and now justly seeking to strengthen ties and expand its influence in its neighbourhood and beyond, observes Dr Rajaram Panda.
Snooping is one of the oldest peccadilloes of man, observes Ambassador M K Bhadrakumar.
The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.
Students who have received admission to foreign universities are struggling with unexpected delays, additional living costs and scarcity of vaccine supplies.
The dry-run was being conducted in state capitals in at least three session sites. Some states also included districts that are situated in difficult terrain or have poor logistical support, according to officials.
'What prevents infection are masks, physical distancing and good ventilation.'
There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.
Interacting with state chief ministers, Modi underscored the enormity of what he described as the world's biggest vaccination exercise, which begins from January 16, saying over 30 crore citizens will get the jabs in the next few months in India against only 2.5 crore people vaccinated so far in over 50 countries in around a month.
Launches cloud-based version of solution to target mid-size clients in life sciences.
'They are starting to move more quickly and we would just like to continue to see bold action being taken.'
Maruti Suzuki, Asian Paints, L&T, ONGC and Infosys have gained between 1%-1.5%.
Loud applause and cheers rang out as the first jabs were administered to frontline workers at hospitals and healthcare centres across the country on Saturday at the start of the gargantuan COVID-19 vaccination exercise, hailed as a 'momentous' occasion in India's fight against the pandemic.
A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine flown to 13 cities across India from Pune and taken to designated national and state-level stores amid tight security.
Not to say that India couldn't have handled the situation better, but on average, it didn't do anywhere near as badly as the naysayers make it out argues Rajeev Srinivasan.
'There is more likelihood of dying from lightning than from vaccine induced blood clots.'
'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'
Investors will maintain a cautious stance.
The first COVID-19 vaccine shots in India were given on Saturday to nearly two lakh frontline healthcare and sanitary workers as Prime Minister Narendra Modi rolled out the world's largest inoculation drive against the pandemic that has caused 1,52,093 deaths and upended millions of lives in the country.
'Even after vaccines are given, precautions like using a mask and maintaining social distancing have to be taken.'
'The government had a vaccine from January.' 'The government should have given the vaccine to all population above the age of 45, right from the start.' 'Each state has its own problems, but as far as vaccine coverage in India is concerned, there have been mistakes.'
'Whenever you roll out: effectiveness is important, operational logistics are important, side effects are important and vaccine hesitancy is important.'
Short-covering and the propping up of net asset values have potential to boost frontline as well as second-rung names next week
'It is absolutely important for us to continue to message to people that they must wear masks, keep physical distancing, as much as is practically possible, at work or at home.'
'Essentially there are three things the government should be doing: Identify who you are going to get your vaccine from, figure out how you are going to pay for it, and figure out how you're going to deliver it and to whom.'
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.
The 30-share Sensex ended up 292 points at 29,571 and the 50-share Nifty closed up 75 points at 8,910.
Sensex, Nifty end the day in red on unfavourable cues from global markets.
Sensex eneded lower on poor perfromance by financials and IT stocks.
Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances